INTESTINAL TRANSIT TIME INCREASED

INTESTINAL TRANSIT TIME INCREASED was reported 32 times

INTESTINAL TRANSIT TIME INCREASED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Guanylate Cyclase-C Agonist [EPC] 1 0.0005
1 mu-Opioid Receptor Agonist [EPC] 1 0.0003
2 Substance P/Neurokinin-1 Receptor Antagonist [EPC] 2 0.0002
3 Lipid-based Polyene Antifungal [EPC] 2 0.0002
4 GLP-2 Analog [EPC] 1 0.0001
5 Interleukin-17A Antagonist [EPC] 2 0.0001
6 Polyene Antifungal [EPC] 2 0.0000
7 Human Immunoglobulin G [EPC] 1 0.0000
8 Programmed Death Ligand-1 Blocker [EPC] 1 0.0000
9 BCL-2 Inhibitor [EPC] 2 0.0000
10 Rifamycin Antibacterial [EPC] 1 0.0000
11 Integrin Receptor Antagonist [EPC] 2 0.0000
12 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 2 0.0000
13 CTLA-4-directed Blocking Antibody [EPC] 1 0.0000
14 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1 0.0000
15 Janus Kinase Inhibitor [EPC] 2 0.0000
16 Central Nervous System Stimulant [EPC] 1 0.0000
17 Purine Antimetabolite [EPC] 1 0.0000
18 Aminosalicylate [EPC] 1 0.0000
19 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1 0.0000
20 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
21 Opioid Agonist [EPC] 2 0.0000
22 Aldosterone Antagonist [EPC] 1 0.0000
23 Azole Antifungal [EPC] 1 0.0000
24 CD20-directed Cytolytic Antibody [EPC] 2 0.0000
25 Microtubule Inhibitor [EPC] 1 0.0000
26 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
27 Proton Pump Inhibitor [EPC] 3 0.0000
28 Anti-epileptic Agent [EPC] 1 0.0000
29 GLP-1 Receptor Agonist [EPC] 2 0.0000
30 Alkylating Drug [EPC] 1 0.0000
31 Platinum-based Drug [EPC] 1 0.0000
32 Osmotic Laxative [EPC] 1 0.0000
33 Nonsteroidal Anti-inflammatory Drug [EPC] 4 0.0000
34 Tumor Necrosis Factor Blocker [EPC] 3 0.0000
35 Corticosteroid [EPC] 3 0.0000
36 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
37 Atypical Antipsychotic [EPC] 1 0.0000
38 Loop Diuretic [EPC] 1 0.0000
39 Benzodiazepine [EPC] 1 0.0000